Measurable weight loss typically starts by week three or four
Combining Tesamorelin and Ipamorelin can potentially offer synergistic effects, enhancing overall efficacy in GH stimulation with potentially fewer side effects than traditional GH therapy: While the combination of Tesamorelin and Ipamorelin can be beneficial, it also comes with potential risks and considerations: Research on both peptides, particularly on their combined use, is still emerging: The combination of Tesamorelin and Ipamorelin represents a promising approach to managing growth hormone levels, offering benefits like reduced abdominal fat, increased muscle mass, and improved recovery, while potentially minimizing the side effects associated with conventional GH therapies
[1] [17] Whilst UK law permits the prescribing of unlicensed medicines in limited circumstances, practical access to retatrutide is effectively restricted to participation in a registered clinical trial
Sarma AV, Foxman B, Bayirli B, Haefner H, Sobel JD